PNTG

Over the past six months, The Pennant Group's stock surged 27%, trading at $31.32 as of May 1, 2026. The company reported strong financial results for Q1 2026, with revenue increasing by 36% year-over-year to $285.4 million and adjusted diluted earnings per share rising 18.5% to $0.32, surpassing analyst expectations. Key events include acquisitions of senior living communities in Arizona and Wisconsin, as well as UnitedHealth Group Incorporated operations in Tennessee, Georgia, and Alabama. Analyst sentiment has been bullish, and the stock benefited from broader healthcare sector rallies, but also experienced declines due to market pullbacks and geopolitical tensions. The company's Q4 2025 revenue surged 53% year-over-year to $289.3 million, and adjusted EPS of $0.34 surpassed forecasts.